$TNDM
TANDEM DIABETES CARE INC Stock $tndm

$tndm Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143813324000086 Filed on May 02, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$221.9M	$191.7M	$169.4M
YoY Change	13.27%	13.16%	-3.71%
Cost Of Revenue	$109.1M	$97.00M	$86.48M
YoY Change	15.86%	12.17%	1.96%
Gross Profit	$112.8M	$94.67M	$82.91M
YoY Change	10.87%	14.19%	-8.99%
Gross Profit Margin	50.83%	49.39%	48.95%
Selling, General & Admin	$94.24M	$90.11M	$89.81M
YoY Change	-3.45%	0.33%	22.58%
% of Gross Profit	83.55%	95.18%	108.33%
Research & Development	$49.33M	$46.24M	$42.16M
YoY Change	14.89%	9.69%	27.14%
% of Gross Profit	43.73%	48.85%	50.85%
Depreciation & Amortization	$4.108M	$4.043M	$3.396M
YoY Change	-3.68%	19.05%	-6.39%
% of Gross Profit	3.64%	4.27%	4.1%
Operating Expenses	$143.6M	$136.4M	$210.7M
YoY Change	2.15%	-35.29%	97.99%
Operating Profit	-$30.77M	-$41.68M	-$127.8M
YoY Change	-20.7%	-67.39%	733.34%
Interest Expense	$1.031M	$3.417M	$4.231M
YoY Change	-75.33%	-19.24%	-484.29%
% of Operating Profit
Other Income/Expense, Net	$1.031M	$2.149M	$4.231M
YoY Change	-75.33%	-49.21%	-484.29%
Pretax Income	-$29.70M	-$39.50M	-$123.6M
YoY Change	-14.16%	-68.04%	653.66%
Income Tax	$1.100M	$3.200M	$300.0K
% Of Pretax Income
Net Earnings	-$30.81M	-$42.72M	-$123.9M
YoY Change	-13.87%	-65.52%	741.81%
Net Earnings / Revenue	-13.89%	-22.29%	-73.13%
Basic Earnings Per Share	-$0.47	-$0.65	-$1.92
Diluted Earnings Per Share	-$0.47	-$0.65	-$1.92
COMMON SHARES
Basic Shares Outstanding	64.59M shares	65.63M shares	64.53M shares
Diluted Shares Outstanding	64.99M shares	65.33M shares	64.55M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$452.4M	$467.8M	$519.6M
YoY Change	-10.81%	-9.97%	-18.23%
Cash & Equivalents	$47.70M	$58.98M	$127.8M
Short-Term Investments	$404.7M	$408.8M	$391.8M
Other Short-Term Assets	$21.20M	$20.53M	$15.38M
YoY Change	97.25%	33.44%	71.8%
Inventory	$161.7M	$153.9M	$131.6M
Prepaid Expenses
Receivables	$98.12M	$92.97M	$91.39M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$733.4M	$735.2M	$757.9M
YoY Change	-4.04%	-3.0%	-7.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$78.63M	$77.53M	$74.58M
YoY Change	6.61%	3.96%	49.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$37.25M	$40.04M	$16.91M
YoY Change	112.03%	136.83%	7.21%
Total Long-Term Assets	$204.1M	$205.9M	$196.2M
YoY Change	11.92%	4.91%	-0.3%
TOTAL ASSETS
Total Short-Term Assets	$733.4M	$735.2M	$757.9M
Total Long-Term Assets	$204.1M	$205.9M	$196.2M
Total Assets	$937.5M	$941.0M	$954.1M
YoY Change	-0.97%	-1.37%	-6.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$47.78M	$48.14M	$55.23M
YoY Change	-16.3%	-12.83%	21.81%
Accrued Expenses	$13.23M	$10.93M	$10.48M
YoY Change	0.8%	4.34%	64.68%
Deferred Revenue	$44.20M	$44.56M	$20.76M
YoY Change	88.88%	114.61%	90.83%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$40.54M
YoY Change
Total Short-Term Liabilities	$240.6M	$193.0M	$171.2M
YoY Change	37.76%	12.75%	29.85%
LONG-TERM LIABILITIES
Long-Term Debt	$307.4M	$347.5M	$283.7M
YoY Change	8.19%	22.5%	0.63%
Other Long-Term Liabilities	$32.50M	$32.48M	$23.80M
YoY Change	30.23%	36.46%	36.41%
Total Long-Term Liabilities	$339.9M	$32.48M	$23.80M
YoY Change	1262.07%	36.46%	36.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$240.6M	$193.0M	$171.2M
Total Long-Term Liabilities	$339.9M	$32.48M	$23.80M
Total Liabilities	$703.6M	$698.0M	$615.4M
YoY Change	13.96%	13.42%	6.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.025B	-$994.5M	-$853.1M
YoY Change	15.36%	16.58%	31.38%
Common Stock	$1.260B	$1.239B	$1.192B
YoY Change	3.38%	3.91%	9.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$233.9M	$243.1M	$338.8M
YoY Change
Total Liabilities & Shareholders Equity	$937.5M	$941.0M	$954.1M
YoY Change	-0.97%	-1.37%	-6.02%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$30.81M	-$42.72M	-$123.9M
YoY Change	-13.87%	-65.52%	741.81%
Depreciation, Depletion And Amortization	$4.108M	$4.043M	$3.396M
YoY Change	-3.68%	19.05%	-6.39%
Cash From Operating Activities	-$5.275M	-$7.996M	-$18.33M
YoY Change	-16.57%	-56.37%	-232.8%
INVESTING ACTIVITIES
Capital Expenditures	$6.466M	$4.457M	$8.828M
YoY Change	-34.63%	-49.51%	234.01%
Acquisitions
YoY Change
Other Investing Activities	$2.926M	-$599.0K	-$17.50M
YoY Change	-81.23%	-96.58%	-323.23%
Cash From Investing Activities	-$3.540M	-$5.056M	-$26.33M
YoY Change	-162.13%	-80.8%	-606.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.002M	$13.59M	-$541.0K
YoY Change	-176.04%	-2611.28%	-115.46%
NET CHANGE
Cash From Operating Activities	-5.275M	-$7.996M	-$18.33M
Cash From Investing Activities	-3.540M	-$5.056M	-$26.33M
Cash From Financing Activities	-3.002M	$13.59M	-$541.0K
Net Change In Cash	-11.82M	$111.0K	-$44.76M
YoY Change	-455.61%	-100.25%	-298.91%
FREE CASH FLOW
Cash From Operating Activities	-$5.275M	-$7.996M	-$18.33M
Capital Expenditures	$6.466M	$4.457M	$8.828M
Free Cash Flow	-$11.74M	-$12.45M	-$27.15M
YoY Change	-27.59%	-54.14%	-343.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17320000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17060000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	44562000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	43994000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	30338000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	28462000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	195258000	usd
CY2024Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	347497000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	285035000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	31830000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	697981000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	639026000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64563000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64563000	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	65000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	66000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1238449000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1263997000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-935000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1369000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-994515000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-951800000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	243064000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	313632000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	941045000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	952658000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191674000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169383000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	192971000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	112732000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	113572000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	12299000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	13331000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32482000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	97002000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	86476000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	94672000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	82907000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	90106000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	89814000	usd
CY2024Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	46244000	usd
CY2023Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	42160000	usd
CY2024Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	usd
CY2023Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	78750000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	136350000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	210724000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-41678000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-127817000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	5314000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	5865000	usd
CY2024Q1	us-gaap	Interest Expense Other InterestExpenseOther	1897000	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	1634000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1268000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2149000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4231000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39529000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-123586000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3186000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	287000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-42715000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-123873000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1296000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1749000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1008000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-25000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-45019000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-122149000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.92
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.92
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65326000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65326000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64549000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64549000	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	313632000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	30000000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	248000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-1759000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21591000	usd
CY2024Q1	tndm	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Purchase Of Capped Call Option AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtPurchaseOfCappedCallOption	15813000	usd
CY2024Q1	tndm	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Partial Termination Of Capped Call Options AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtPartialTerminationOfCappedCallOptions	184000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1296000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-42715000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	243064000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	439947000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	857000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-1398000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21496000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1749000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-25000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-123873000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	338753000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-42715000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-123873000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4043000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3396000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	650000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	503000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2198000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1386000	usd
CY2024Q1	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	434000	usd
CY2023Q1	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-312000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	22039000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	21194000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1268000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	0	usd
CY2023Q1	us-gaap	Research And Development Asset Acquired Other Than Through Business Combination Written Off ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff	78750000	usd
CY2024Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	52000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	94000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-9765000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22845000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3157000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19916000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4104000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5208000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	236000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	386000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3369000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-919000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1654000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-210000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-372000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	925000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	883000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	2895000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	833000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-114000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7996000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18326000	usd
CY2024Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	84249000	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	109115000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	83650000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	163110000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4457000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8828000	usd
CY2024Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	0	usd
CY2023Q1	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	69496000	usd
CY2024Q1	tndm	Payments To Acquire Intangible Assets And Strategic Investments PaymentsToAcquireIntangibleAssetsAndStrategicInvestments	0	usd
CY2023Q1	tndm	Payments To Acquire Intangible Assets And Strategic Investments PaymentsToAcquireIntangibleAssetsAndStrategicInvestments	2000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5056000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26329000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	9400000	usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	306850000	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2024Q1	us-gaap	Debt Instrument Repurchased Face Amount DebtInstrumentRepurchasedFaceAmount	246740000	usd
CY2024Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	246123000	usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2024Q1	tndm	Payments For Capped Call Transactions PaymentsForCappedCallTransactions	15813000	usd
CY2023Q1	tndm	Payments For Capped Call Transactions PaymentsForCappedCallTransactions	0	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	30000000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-1511000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-541000	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	183000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13586000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-541000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-423000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	441000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	111000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-44755000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58868000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	172517000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58979000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	127762000	usd
CY2024Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	269000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	369000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2294000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3214000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4071000	usd
CY2024Q1	tndm	Intangible Costs In Other Current And Other Long Term Liabilities IntangibleCostsInOtherCurrentAndOtherLongTermLiabilities	0	usd
CY2023Q1	tndm	Intangible Costs In Other Current And Other Long Term Liabilities IntangibleCostsInOtherCurrentAndOtherLongTermLiabilities	515000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions.</span></div>
CY2023Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	10100000	usd
CY2024Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	10100000	usd
CY2023	tndm	Number Of Investments Held By The Company NumberOfInvestmentsHeldByTheCompany	2	investment
CY2024Q1	tndm	Number Of Investments Held By The Company NumberOfInvestmentsHeldByTheCompany	2	investment
CY2024Q1	tndm	Investment Owned Ownership Interest InvestmentOwnedOwnershipInterest	0.05
CY2024Q1	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	31500000	usd
CY2023Q4	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	30600000	usd
CY2024Q1	tndm	Estimated Sales Rebates Current EstimatedSalesRebatesCurrent	493000	usd
CY2023Q4	tndm	Estimated Sales Rebates Current EstimatedSalesRebatesCurrent	505000	usd
CY2024Q1	tndm	Estimated Sales Rebates Noncurrent EstimatedSalesRebatesNoncurrent	8260000	usd
CY2023Q4	tndm	Estimated Sales Rebates Noncurrent EstimatedSalesRebatesNoncurrent	8042000	usd
CY2024Q1	tndm	Estimated Sales Rebates EstimatedSalesRebates	8753000	usd
CY2023Q4	tndm	Estimated Sales Rebates EstimatedSalesRebates	8547000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7924000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5449000	shares
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	37173000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	36537000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	10409000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	8373000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	9037000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	7683000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-907000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-75000	usd
CY2024Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	37638000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	37152000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	18166000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	18135000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	19472000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	19038000	usd
CY2024Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	37638000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	37173000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	409378000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	278000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	825000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	408831000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	408295000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1025000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	276000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	409044000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	212174000	usd
CY2024Q1	tndm	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year One Through Two DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo	129640000	usd
CY2024Q1	tndm	Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year Two Through Three DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearTwoThroughThree	67017000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	408831000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	97888000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	110453000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4923000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4898000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	92965000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	105555000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4898000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4327000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2198000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1386000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2173000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1246000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4923000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4467000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	52850000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	42783000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	21883000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	44026000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	79160000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	71128000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	153893000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	157937000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	4051000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	4475000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	21000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	96000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	4072000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	4571000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	12943000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	17623000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	17506000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	17771000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	14278000	usd
CY2024Q1	tndm	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	90004000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	170125000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	40073000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	130052000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17320000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	112732000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y10M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y2M12D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.053
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.054
CY2024Q1	tndm	Operating Lease Cash Payments OperatingLeaseCashPayments	4700000	usd
CY2023Q1	tndm	Operating Lease Cash Payments OperatingLeaseCashPayments	1800000	usd
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	17668000	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2023Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2602184	shares
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22039000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21194000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1500000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	2000000	usd
CY2024Q1	tndm	Defined Contribution Plan Minimum Age Of Employee DefinedContributionPlanMinimumAgeOfEmployee	P18Y
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3200000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39500000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-123600000	usd
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191674000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169383000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	191674000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169383000	usd
CY2022Q3	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	8000000	chf
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	4900000	usd

Files In Submission

Name	View Source	Status
0001438133-24-000086-index-headers.html	Edgar Link	pending
0001438133-24-000086-index.html	Edgar Link	pending
0001438133-24-000086.txt	Edgar Link	pending
0001438133-24-000086-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tndm-20240331.htm	Edgar Link	pending
tndm-20240331.xsd	Edgar Link	pending
tndm-20240331xex311.htm	Edgar Link	pending
tndm-20240331xex312.htm	Edgar Link	pending
tndm-20240331xex321.htm	Edgar Link	pending
tndm-20240331xex322.htm	Edgar Link	pending
tndm-20240331_def.xml	Edgar Link	unprocessable
tndm-20240331_lab.xml	Edgar Link	unprocessable
tndm-20240331_pre.xml	Edgar Link	unprocessable
tndm-20240331_htm.xml	Edgar Link	completed
tndm-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TNDM
TANDEM DIABETES CARE INC Stock $tndm

2024 Q2 Form 10-Q Financial Statement

#000143813324000086 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TNDM TANDEM DIABETES CARE INC Stock $tndm

2024 Q2 Form 10-Q Financial Statement

#000143813324000086 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TNDM
TANDEM DIABETES CARE INC Stock $tndm